Search Tag: Abbott
Empower your Laboratory with Total Value of Ownership
2018 16 Oct
Taking place at 7:00am PDT, 10:00am EDT, 4:00pm CEST Read more
Foreword
2018 21 Aug
Emilie Neukom Director of Marketing for EMEA, Abbott Diagnostics The global healthcare sector has been undergoing constant upheaval for over a decade. Aging populations, budget restrictions and a lack of skilled staff are making it harder than ever before to deliver high quality healthcare, and laboratory diagnostic services have suffered... Read more
Elevating the clinical laboratory’s role in healthcare delivery
2018 21 Aug
David Humphreys Global Head of Health Policy, The Economist Intelligence Unit (EIU) Abbott recently commissioned a study by the Economist Intelligence Unit – supported by research partners IPSOS and Acuity – to examine the laboratory’s current influence and perception, as well as to explore initiatives that could increase the impact of... Read more
Changing the status quo – big data and disruptive technologies
2018 21 Aug
Utilizing big data for better care Jan-Philipp Beck &nbs Read more
The lab as the 'Uber' of medicine
2018 21 Aug
Khosrow Shotorbani CEO and founder of the lab 2.0 Strategic Services Healthcare systems globally are undergoing a paradigm shift from ‘sick care’ to ‘well care’. With budgets becoming ever more stretched, cost avoidance through disease prevention and early intervention are the only viable option – we can no longer afford to simply care... Read more
Abbott – a trusted partner
2018 21 Aug
Paul Jülicher Director International Health Economics & Outcomes Research, Abbott Diagnostics Matt Sawtell General Manager Nordics, Abbott Diagnostics Unleashing the value of IVD testing The value of in vitro diagnostic services is like beauty – it's very much in the eye of the beholder. From a community perspective,... Read more
Abbott Announces CE Mark For its "Alinity S" Blood and Plasma Screening System
2017 12 Jan
Abbott (NYSE: ABT) has announced its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other countries that recognize CE Mark. The new testing solution is designed to screen blood and plasma faster and more efficiently within a smaller footprint than Abbott's current systems. In a testing specialty... Read more
Establishment of Ambulatory Emergency Services at James Paget University Hospital
2016 09 Dec
INTRODUCTION A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero). 1 This suggests that many emergency patients could benefit from ambulatory emergency care (AEC). 1 Fundamental to AEC is the identification and management of patients with... Read more
Abbott To Take Over St Jude in $25 bln Mega-Cardio Deal
2016 28 Apr
Abbott Laboratories is taking over St. Jude Medical Inc. in a deal worth $25 bln that will create a giant in the cardio-related devices market. The two NYSE-listed companies said in a joint announcement that the combination will “create a premier medical device leader and strengthen Abbott’s long-term growth potential.” They added that the... Read more
Abbott to Acquire Alere,Becoming Leader in Point of Care Testing & Advancing Global Diagnostics
2016 18 Feb
ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS - Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close - Acquisition will provide access to new product applications, channels and geographies -... Read more